Designs for a second South Australian Health and Medical Research Institute building – dubbed SAHMRI 2 – has been unveiled by architecture firm Woods Bagot.
The proposed $273 million SAHMRI sequel will be the latest addition to Adelaide's $3.6 billion BioMed precinct located in the north-west corner of the CBD.
The precinct, which is the largest health cluster in the Southern Hemisphere, unifies research, education, clinical care and business development.
The new medical building will be position alongside the flagship SAHMRI, known for its striking pine-cone-like geometric facade.
"The original SAHMRI was a catalyst in the resurrection of inner-city Adelaide, and the evolution of an internationally-regarded health and biomedical precinct," Woods Bagot director Thomas Masullo said.
"The design of SAHMRI 2 echoes the gravitas of this precinct where state of the art technology is part of the city's ongoing transformation."
When complete SAHMRI 2 will house Australia's first proton therapy unit for cancer treatment.
The therapy unit will deliver the most technologically advanced radiation therapy in the Southern Hemisphere.
"The vision for SAHMRI 2 is to provide flexible, intelligent and high-performance research and workspaces that connect people across teams, disciplines and generations."
SAHMRI 2 will have three frontages, one to North terrace and the city, one to the nearby river, and one to Adelaide’s convention and entertainment precinct.
Since the completion of SAHMRI in 2013, the new Royal Adelaide Hospital has opened last year and the universities of Adelaide Health and Medical Sciences Building and South Australia Health Innovation Building have established relevant presences.
It is expected a new women's and children's hospital will be co-located with the RAH in time.
The existing SAHMRI was Australia's first laboratory building to be certified as a Leadership in Energy and Environment Design (LEED) Gold building.
Similar high sustainability standards for the design are being applied to the SAHMRI 2 project with is expected to be completed by 2021.